These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. DIFFERENTIAL THERAPEUTIC RESULTS OF THREE ANTIDEPRESSANT MEDICATIONS ACCORDING TO FIXED OR FUNCTIONAL SCHEDULES. HAYDU GG; WHITTIER JR; GOLDSCHMIDT L; KORENYI C J Nerv Ment Dis; 1964 Nov; 139():475-8. PubMed ID: 14231162 [No Abstract] [Full Text] [Related]
44. Tranylcypromine and trifluoperazine in the management of the menopausal syndrome. MAZZA PA Dis Nerv Syst; 1962 Apr; 23():224-5. PubMed ID: 14471846 [No Abstract] [Full Text] [Related]
45. DROPOUT IN AN OUTPATIENT, DOUBLE-BLIND DRUG STUDY. GLICK BS Psychosomatics; 1965; 6():44-8. PubMed ID: 14263749 [No Abstract] [Full Text] [Related]
46. [ACUTE HYPERTENSION DUE TO MONOAMINE OXIDASE INHIBITORS AND THE EATING OF CHEESE]. MUSCHOLL E Dtsch Med Wochenschr; 1965 Jan; 90():38-9. PubMed ID: 14225054 [No Abstract] [Full Text] [Related]
48. NONOAMINE OXIDASE INHIBITORS VERSUS IMINODIBENZYL DERIVATIVES IN THE TREATMENT OF DEPRESSION. A COMPARATIVE CLINICAL STUDY OF IMPIRAMINE AND PHENIPRAZINE. ABD-EL-NABY S; AMIN N; SAAD AF J Egypt Med Assoc; 1964; 47():189-203. PubMed ID: 14228573 [No Abstract] [Full Text] [Related]
49. EARLY RECOGNITION OF DEPRESSION. FELLNER CH Geriatrics; 1964 Dec; 19():920-6. PubMed ID: 14226253 [No Abstract] [Full Text] [Related]
50. [PSYCHOTIC TRANSITIONS OF PSYCHONEUROSES. I. FROM NEURASTHENIA TO SECONDARY MELANCHOLIA AND HYPOCHONDRIA]. PIAZZA M G Psichiatr Neuropatol; 1964; 92():193-245. PubMed ID: 14176204 [No Abstract] [Full Text] [Related]
51. CHEESE AND MONOAMINE OXIDASE INHIBITORS. INTERACTION IN ANAESTHETISED CATS. NATOFF IL Lancet; 1964 Mar; 1(7332):532-3. PubMed ID: 14100189 [No Abstract] [Full Text] [Related]
52. THE PUBLIC INTEREST AND DRUG RECALL. KRAINES SH JAMA; 1964 May; 188():612. PubMed ID: 14159074 [No Abstract] [Full Text] [Related]
53. [INITIATION OF ACTION OF THE MAO-INHIBITOR NIAMIDE IN DEPRESSION]. RADMAYR E Wien Med Wochenschr; 1964 Feb; 114():136-8. PubMed ID: 14137333 [No Abstract] [Full Text] [Related]
54. Clinical experiments with monoamino oxidase inhibitors on a psychiatric clientele. Gottfries CG Acta Psychiatr Scand; 1961; 36(4):539-52. PubMed ID: 13707432 [No Abstract] [Full Text] [Related]
55. CONTROLLING MAO INHIBITOR HYPOTENSION. SIMONSON M Am J Psychiatry; 1964 May; 120():1118-9. PubMed ID: 14144442 [No Abstract] [Full Text] [Related]
56. Tranylcypromine in mind (Part I): Review of pharmacology. Ulrich S; Ricken R; Adli M Eur Neuropsychopharmacol; 2017 Aug; 27(8):697-713. PubMed ID: 28655495 [TBL] [Abstract][Full Text] [Related]
57. [Clinical study of a new thymoleptic agent:Parnate SKF]. LUMINET D; DE DOWIAKOWSKI ML Acta Neurol Psychiatr Belg; 1962 Jun; 62():619-39. PubMed ID: 13931643 [No Abstract] [Full Text] [Related]
58. [Data on experimental and clinical study of a new monoamine oxidase inhibitor-transamine]. GRINSHTEIN VIa; RATENBERG NS; MOROZOVA TN Zh Nevropatol Psikhiatr Im S S Korsakova; 1962; 62():1806-12. PubMed ID: 13950558 [No Abstract] [Full Text] [Related]
59. Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. COPPEN A; SHAW DM; FARRELL JP Lancet; 1963 Jan; 1(7272):79-81. PubMed ID: 14022907 [No Abstract] [Full Text] [Related]